Literature DB >> 30295707

Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.

Taizo Kimura1, Kazuko Tajiri1, Akira Sato1, Satoshi Sakai1, Zheng Wang1, Toshimichi Yoshida2,3, Toshimitsu Uede4, Michiaki Hiroe3,5, Kazutaka Aonuma1, Masaki Ieda1, Kyoko Imanaka-Yoshida2,3.   

Abstract

AIMS: Tenascin-C (TN-C) is an extracellular matrix protein undetected in the normal adult heart, but expressed in several heart diseases associated with inflammation. We previously reported that serum TN-C levels of myocardial infarction (MI) patients were elevated during the acute stage, and that patients with high peak TN-C levels were at high risk of left ventricular (LV) remodelling and poor outcome, suggesting that TN-C could play a significant role in the progression of ventricular remodelling. However, the detailed molecular mechanisms associated with this process remain unknown. We aimed to elucidate the role and underlying mechanisms associated with TN-C in adverse remodelling after MI. METHODS AND
RESULTS: MI was induced by permanent ligation of the coronary artery of TN-C knockout (TN-C-KO) and wild type (WT) mice. In WT mice, TN-C was expressed at the borders between intact and necrotic areas, with a peak at 3 days post-MI and observed in the immediate vicinity of infiltrating macrophages. TN-C-KO mice were protected from ventricular adverse remodelling as evidenced by a higher LV ejection fraction as compared with WT mice (19.0 ± 6.3% vs. 10.6 ± 4.4%; P < 0.001) at 3 months post-MI. During the acute phase, flow-cytometric analyses showed a decrease in F4/80+CD206lowCD45+ M1 macrophages and an increase in F4/80+CD206highCD45+ M2 macrophages in the TN-C-KO heart. To clarify the role of TN-C on macrophage polarization, we examined the direct effect of TN-C on bone marrow-derived macrophages in culture, observing that TN-C promoted macrophage shifting into an M1 phenotype via Toll-like receptor 4 (TLR4). Under M2-skewing conditions, TN-C suppressed the expression of interferon regulatory factor 4, a key transcription factor that controls M2-macrophage polarization, via TLR4, thereby inhibiting M2 polarization.
CONCLUSION: These results suggested that TN-C accelerates LV remodelling after MI, at least in part, by modulating M1/M2-macrophage polarization. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Inflammation ; Macrophage; Myocardial infarction ; Remodelling ; Tenascin-C

Mesh:

Substances:

Year:  2019        PMID: 30295707     DOI: 10.1093/cvr/cvy244

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  21 in total

Review 1.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 2.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 3.  The fibrogenic niche in kidney fibrosis: components and mechanisms.

Authors:  Li Li; Haiyan Fu; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2022-07-04       Impact factor: 42.439

4.  LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.

Authors:  Akif Altinbas; Jacinta A Holmes; Shadi Salloum; Anna Lidofsky; Nadia Alatrakchi; Ma Somsouk; Peter Hunt; Steven Deeks; Kara W Chew; Georg Lauer; Annie Kruger; Wenyu Lin; Raymond T Chung
Journal:  Biomark Med       Date:  2022-07-05       Impact factor: 2.498

5.  Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.

Authors:  Claire Deligne; Devadarssen Murdamoothoo; Anís N Gammage; Martha Gschwandtner; William Erne; Thomas Loustau; Anna M Marzeda; Raphael Carapito; Nicodème Paul; Inés Velazquez-Quesada; Imogen Mazzier; Zhen Sun; Gertraud Orend; Kim S Midwood
Journal:  Cancer Immunol Res       Date:  2020-01-15       Impact factor: 11.151

Review 6.  Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.

Authors:  Motomichi Fujita; Manabu Sasada; Takuya Iyoda; Fumio Fukai
Journal:  Molecules       Date:  2020-07-16       Impact factor: 4.411

7.  Icariside II ameliorates myocardial ischemia and reperfusion injury by attenuating inflammation and apoptosis through the regulation of the PI3K/AKT signaling pathway.

Authors:  Bing-Feng Guan; Xiao-Feng Dai; Qi-Bin Huang; Di Zhao; Jin-Long Shi; Cheng Chen; Yan Zhu; Fen Ai
Journal:  Mol Med Rep       Date:  2020-07-31       Impact factor: 2.952

8.  Tenascin-C: an emerging prognostic biomarker in diabetes.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Siqi Li; Akira Sato
Journal:  Ann Transl Med       Date:  2020-12

Review 9.  Tenascin-C in Heart Diseases-The Role of Inflammation.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

10.  MAIR-II deficiency ameliorates cardiac remodelling post-myocardial infarction by suppressing TLR9-mediated macrophage activation.

Authors:  Saori Yonebayashi; Kazuko Tajiri; Nobuyuki Murakoshi; Dongzhu Xu; Siqi Li; Duo Feng; Yuta Okabe; Zixun Yuan; Zonghu Song; Kazuhiro Aonuma; Akira Shibuya; Kazutaka Aonuma; Masaki Ieda
Journal:  J Cell Mol Med       Date:  2020-11-02       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.